Clinical Implication of DAC (Detrusor After-contraction) (DAC)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01154946 |
Recruitment Status :
Completed
First Posted : July 1, 2010
Last Update Posted : July 1, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The aims of this study are
- to confirm whether detrusor after-contraction (DAC) is a true contraction or not with a new approach
- and to understand clinical implication of DAC
Condition or disease |
---|
Voiding Dysfunction |
Study Type : | Observational |
Actual Enrollment : | 2309 participants |
Observational Model: | Case-Control |
Time Perspective: | Retrospective |
Official Title: | A New Approach to Clinical Implication of Detrusor After-contraction (DAC) |
Study Start Date : | January 2007 |
Actual Primary Completion Date : | December 2008 |
Actual Study Completion Date : | December 2008 |
Group/Cohort |
---|
DAC group
patients who show detrusor after-contraction during voiding cystometrography (CMG)
|
- to confirm whether DAC is a true contraction or not [ Time Frame: up to 2 years (2007.Jan-2008.Dec) ]no change of Pdet when patients cough could confirm that DAC was a true contraction. Because an artifact occurred when a catheter was pressed against bladder wall or urethra, no change of intravesical pressure and increase of abdominal pressure finally induced a negative deflection of Pdet and this change of Pdet could be regarded as an artifact.
- Past medical history including neurological disorders and pelvic irradiation were also included in the database [ Time Frame: up to 2 years (2007.Jan-2008.Dec) ]One-way analysis of variance and the chi-square test were performed to determine whether there was a relationship between the presence of DAC and the underlying neurogenic and non-neurogenic conditions

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Indications and selection of patients for conduction of urodynamic studies (UDS) were followed as the recommendation of ICS (international continence society).
Exclusion Criteria:
- Patients with indwelling catheters, urinary tract infection and urinary stones were excluded from this study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01154946
Korea, Republic of | |
Seoul National University Hospital | |
Seoul, Korea, Republic of, 110-744 |
Principal Investigator: | Seung-June Oh, M.D.,Ph.D. | Seoul National University Hospital |
Responsible Party: | Seoul National University Hospital |
ClinicalTrials.gov Identifier: | NCT01154946 |
Other Study ID Numbers: |
DAC H-0805-056-245 |
First Posted: | July 1, 2010 Key Record Dates |
Last Update Posted: | July 1, 2010 |
Last Verified: | June 2010 |
detrusor after-contraction urodynamic LUTS urinary bladder, overactive bladder dysfunction |